Adherium (ADRM.D) Stock Overview

A digital health company, develops, manufactures, and supplies digital health technologies that address sub-optimal medication use in chronic diseases in New Zealand, Australia, Europe, and North America. More details

ADRM.D fundamental analysis
Snowflake Score
Valuation	2/6
Future Growth	2/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Rewards

Trading at 98.4% below our estimate of its fair value

Revenue is forecast to grow 107.97% per year

Risk Analysis

Does not have a meaningful market cap ($4M)

Shareholders have been substantially diluted in the past year

Has less than 1 year of cash runway

Shares are highly illiquid

+ 3 more risks

ADRM.D Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

NEW483,974 members

Join community and earn perks

Gain real feedbackFrom our editorial team, personally. Not silence.

Grow your followingReal investors. The kind who actually invest, not scroll past.

Unlock free accessFree premium subscription for consistent and quality authors.

Learn more Create Narrative

483,974 investors already sharing narratives

View all narratives

Adherium Limited Competitors

Price History & Performance

Summary of share price highs, lows and changes for Adherium
Historical stock prices
Current Share Price	AU$0.30
52 Week High	AU$0.30
52 Week Low	AU$0.30
Beta	1.05
1 Month Change	0%
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	0%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	ADRM.D	US Healthcare Services	US Market
7D	0%	-4.5%	-1.1%
1Y	n/a	-39.8%	15.1%

Return vs Industry: Insufficient data to determine how ADRM.D performed against the US Healthcare Services industry.

Return vs Market: Insufficient data to determine how ADRM.D performed against the US Market.

Price Volatility

Is ADRM.D's price volatile compared to industry and market?
ADRM.D volatility
ADRM.D Average Weekly Movement	n/a
Healthcare Services Industry Average Movement	9.5%
Market Average Movement	7.1%
10% most volatile stocks in US Market	16.1%
10% least volatile stocks in US Market	3.2%

Stable Share Price: ADRM.D's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine ADRM.D's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2001	n/a	Dawn Bitz	www.adherium.com

Adherium Limited, a digital health company, develops, manufactures, and supplies digital health technologies that address sub-optimal medication use in chronic diseases in New Zealand, Australia, Europe, and North America. The company offers Hailie Smartinhaler, a system for management of chronic respiratory conditions, including asthma and chronic obstructive pulmonary disease. It also provides Hailie Smartinhaler sensors; Hailie Solution; and Hailie Remote Patient Monitoring (RPM) Solution.

Adherium Limited Fundamentals Summary

How do Adherium's earnings and revenue compare to its market cap?
ADRM.D fundamental statistics
Market cap	US$4.02m
Earnings (TTM)	-US$8.91m
Revenue (TTM)	US$780.62k

5.2x

P/S Ratio

-0.5x

P/E Ratio

Is ADRM.D overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ADRM.D income statement (TTM)
Revenue	AU$1.12m
Cost of Revenue	AU$731.02k
Gross Profit	AU$387.29k
Other Expenses	AU$13.15m
Earnings	-AU$12.76m

Last Reported Earnings

Dec 31, 2025

Next Earnings Date

n/a

Earnings per share (EPS)	-0.23
Gross Margin	34.63%
Net Profit Margin	-1,141.40%
Debt/Equity Ratio	-166.2%

How did ADRM.D perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/07/25 23:43
End of Day Share Price	2026/06/23 00:00
Earnings	2025/12/31
Annual Earnings	2025/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Adherium Limited is covered by 4 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
John Hester	Bell Potter
Dennis Hulme	Edison Investment Research
Chris Kallos	MST Financial Services Pty Limited